You are here: Home » News-CM » Companies » Results
Business Standard

Kilitch Drugs (India) standalone net profit rises 92.22% in the December 2018 quarter

Capital Market 

Sales rise 48.12% to Rs 19.33 crore

Net profit of rose 92.22% to Rs 3.46 crore in the quarter ended December 2018 as against Rs 1.80 crore during the previous quarter ended December 2017. Sales rose 48.12% to Rs 19.33 crore in the quarter ended December 2018 as against Rs 13.05 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales19.3313.05 48 OPM %23.3316.70 -PBDT4.842.23 117 PBT4.531.93 135 NP3.461.80 92

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, February 13 2019. 10:46 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU